Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Salivaomics as a Potential Tool for Predicting Alzheimer’s Disease During the Early Stages of Neurodegeneration

15 Jun 2021

Abstract excerpt

BACKGROUND: The metabolomic and proteomic basis of mild cognitive impairment (MCI) and Alzheimer's disease (AD) is poorly understood and the relationships between systemic abnormalities in metabolism and AD/AMCI pathogenesis are unclear. OBJECTIVE: The aim of the study was to compare the metabolomic and proteomic signature of saliva from cognitively normal and patients diagnosed with MCI or AD, to identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Metabolomics and Mass Spectrometry Studies
Share to Salivary Gland Disorders and Functions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34151801
DOI: 10.3233/jad-210283

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Salivaomics as a Potential Tool for Predicting Alzheimer’s Disease During the Early Stages of NeurodegenerationPMID 34151801Read ↗

Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer’s diseaseSemantic proximity Read ↗

Saliva Proteome, Metabolome and Microbiome Signatures for Detection of Alzheimer’s DiseaseSemantic proximity Read ↗

Sex Differences in the Metabolome of Alzheimer's Disease ProgressionSemantic proximity Read ↗

Brain cross-omics integration in Alzheimer’s diseaseSemantic proximity Read ↗

Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s diseaseSemantic proximity Read ↗

Recent advances in the application of metabolomics to Alzheimer's DiseaseSemantic proximity Read ↗

Untargeted metabolomics reveals sugar and homocysteine dysregulations in prodromal ADSemantic proximity Read ↗

Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneitySemantic proximity Read ↗

Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer’s disease: A literature reviewSemantic proximity Read ↗

Alteration of Metabolic Profile During the Progression of Alzheimer’s DiseaseSemantic proximity Read ↗

Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer’s diseaseSemantic proximity Read ↗

Advancements in multi-omics research to address challenges in Alzheimer’s disease: a systems biology approach utilizing molecular biomarkers and innovative strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.